Company / Inventory
Thermo Fisher Scientific Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$5.4B
FY2025
5-year range
$5.0B / $5.6B
FY2021-FY2025
Trend
+9.0%
vs FY2024
Sector context
#7 of 115
Health Care
What the data says
Among 115 Health Care companies, Thermo Fisher Scientific is in the top 6% for inventory. Inventory returned to growth in FY2025 after 2 years of decline, reaching $5.4B.
Based on SEC 10-K filings.
$5.4B in FY2025 with a 5-year CAGR of +6.1%. Top quartile in the Health Care sector.
Improved from $5.1B to $5.4B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 115This company $5.4B Sector average $1.4B
▼
+286.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +6.1%, indicating consistent growth.
- In FY2025, inventory increased 9.0% year-over-year.
- Ranks #7 out of 115 companies in the Health Care sector.
- Peak inventory was recorded in FY2022.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.4B | +9.0% |
| FY2024 | $5.0B | -2.2% |
| FY2023 | $5.1B | -9.7% |
| FY2022 | $5.6B | +11.5% |
| FY2021 | $5.1B | +25.4% |
| FY2020 | $4.0B | +19.6% |
| FY2019 | $3.4B | +23.9% |
| FY2018 | $2.7B | -8.5% |
| FY2017 | $3.0B | +34.3% |
| FY2016 | $2.2B | +11.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026